Answers are grounded in this paper and cite their sources.
Exploration identifies barriers in maternal-fetal healthcare, suggesting interdisciplinary collaboration is essential.
The development of safe and effective maternal-fetal therapeutics is significantly hindered by chronic underfunding, inequitable access to specialized care, and persistent sociopolitical stigmas surrounding women’s health. Addressing these challenges will require interdisciplinary collaboration between clinicians, scientists, and engineers to design accessible therapeutics for maternal-fetal healthcare.
No takes yet. Share an insight, caveat, or question.
Howlett et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: